Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Basser

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
British Journal of Haematology|June 1, 1997
Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDFJ E Rasko, R L Basser, J Boyd, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-upM Colleoni, Z Sun, G Martinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrinM A Rosenthal, B Kavar, J S Hill, et al.
Blood|November 1, 1996
Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activationC J O'Malley, J E Rasko, R L Basser, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humansS I van Leuven, R S Birjmohun, R Franssen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade gliomaK Clarke, R L Basser, C Underhill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factorR L Basser, L B To, C G Begley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-upR L Basser, L B To, J P Collins, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
British Journal of Haematology|June 1, 1997
Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDFJ E Rasko, R L Basser, J Boyd, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-upM Colleoni, Z Sun, G Martinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrinM A Rosenthal, B Kavar, J S Hill, et al.
Blood|November 1, 1996
Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activationC J O'Malley, J E Rasko, R L Basser, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humansS I van Leuven, R S Birjmohun, R Franssen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade gliomaK Clarke, R L Basser, C Underhill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factorR L Basser, L B To, C G Begley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-upR L Basser, L B To, J P Collins, et al.
Pageof 4